13F Holdings
中文EN

NVCT Nuvectis Pharma, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1875558 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-98.8%
TTM EPS YoY-46.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-67.0%
ROA-57.2%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets10.1%
Debt / equity0.00x
Current ratio9.92x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.80x
Accruals ratio-11.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue—————
R&D expense$18.15M$12.92M$15.38M$13.23M$9.54M
SG&A expense$9.42M$6.93M$7.52M$6.01M$3.35M
Operating income-$27.57M-$19.85M-$22.90M-$19.23M-$12.89M
Net income-$26.44M-$19.00M-$22.26M-$19.09M-$12.89M
EPS (basic)-1.32-1.11-1.43-1.51-3.02
EPS (diluted)-1.32-1.11-1.43-1.51-3.02
Dividends declared per share0.000.000.000.00—
Weighted avg. shares (diluted)21.81M17.11M15.56M12.66M4.27M
Balance sheet
Cash & equivalents$31.63M$18.53M$19.13M$19.99M$5.74M
Current assets$31.71M$18.61M$19.18M$20.41M$5.83M
Total assets$31.71M$18.61M$19.18M$20.41M$6.66M
Current liabilities$13.30M$8.89M$6.98M$6.19M$2.42M
Total liabilities$13.30M$8.89M$6.98M$6.19M$2.42M
Shareholders' equity$18.41M$9.71M$12.20M$14.22M-$11.01M
Shares outstanding25.68M19.50M17.42M15.19M4.51M
Cash flow statement
Operating cash flow-$16.01M-$12.25M-$15.95M-$13.56M-$9.50M
Investing cash flow—$0$0$0—
Financing cash flow$29.11M$11.65M$15.09M$27.81M$15.25M
Stock-based compensation$6.03M$4.86M$4.71M$1.71M$1.89M

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.